Company Filing History:
Years Active: 1987
Title: Anil K Singhal: Innovator in Tumor Detection Technology
Introduction
Anil K Singhal is a prominent inventor based in Edmonds, WA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of tumor-associated antigens. His innovative approach has the potential to enhance the accuracy of cancer detection, thereby improving patient outcomes.
Latest Patents
Anil K Singhal holds a patent for an "Immune complex assay," which presents a novel method for detecting tumor-associated antigens in a patient's serum or plasma samples. This method involves applying the patient's serum sample to an immunoadsorbent column to enrich the amount of immune complexes relative to other serum components. The tumor-associated antigen is then detected in the enriched sample using a solid-phase assay that employs a solid-phase receptor for the immune complexes and a labeling system specific for the tumor-associated antigen. He has 1 patent to his name.
Career Highlights
Anil K Singhal is associated with Imre Corporation, where he continues to work on advancing diagnostic technologies. His expertise in immunology and assay development has positioned him as a key player in the field of cancer diagnostics.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Anil K Singhal's innovative work in tumor detection technology exemplifies the impact of scientific research on healthcare. His contributions are paving the way for more effective cancer diagnostics, ultimately benefiting patients and the medical community.